BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 18815881)

  • 1. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.
    Thomas NB; Hutcheson IR; Campbell L; Gee J; Taylor KM; Nicholson RI; Gumbleton M
    Breast Cancer Res Treat; 2010 Feb; 119(3):575-91. PubMed ID: 19288272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of survivin expression by small interfering RNA induces apoptosis in human breast carcinoma cell line MCF-7.
    Li JX; Zhou KY; Liang T; Zhang YF
    Ai Zheng; 2005 Mar; 24(3):268-72. PubMed ID: 15757525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
    Fu Y; Li J; Lee AS
    Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
    Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
    Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.
    Zhang Y; Chen ZD; Du CJ; Xu G; Luo W
    Pathol Res Pract; 2009; 205(12):823-7. PubMed ID: 19628339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
    Hou JQ; He J; Wang XL; Wen DG; Chen ZX
    Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
    Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
    Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
    Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of survivin siRNA expression vector and its regulation on cell cycle and proliferation in MCF-7 cells.
    Li LP; Liang NC; Luo CQ
    Ai Zheng; 2004 Jul; 23(7):742-8. PubMed ID: 15248905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
    Nakao K; Hamasaki K; Ichikawa T; Arima K; Eguchi K; Ishii N
    Oncol Rep; 2006 Aug; 16(2):389-92. PubMed ID: 16820920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein.
    Shi Z; Liang YJ; Chen ZS; Wang XH; Ding Y; Chen LM; Fu LW
    Oncol Rep; 2007 Apr; 17(4):969-76. PubMed ID: 17342344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.
    Xia W; Bisi J; Strum J; Liu L; Carrick K; Graham KM; Treece AL; Hardwicke MA; Dush M; Liao Q; Westlund RE; Zhao S; Bacus S; Spector NL
    Cancer Res; 2006 Feb; 66(3):1640-7. PubMed ID: 16452223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway.
    Croci DO; Cogno IS; Vittar NB; Salvatierra E; Trajtenberg F; Podhajcer OL; Osinaga E; Rabinovich GA; Rivarola VA
    J Cell Biochem; 2008 Oct; 105(2):381-90. PubMed ID: 18553460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; K├╝hnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.